-
2022.04.21
J-Pharma Announces FDA Orphan Drug Designation for JPH203 for the Treatment of Biliary Tract Cancer
-
What's new
- J-Pharma Announces FDA Orphan Drug Designation for JPH203 for the Treatment of Biliary Tract Cancer 2022/04/21
- J-Pharma to Present at The 40th Annual J.P. Morgan Healthcare Conference 2022/01/05
- Participation in the Startup City Acceleration Program 2021/11/22
- J-Pharma Raises 600 Million JPY from JIC Venture Growth Investments(VGI) 2021/07/30
- Organization and Personnel Changes 2021/03/16
-
Monthly